Search - tctmd.com

Displaying 101 - 120 of 227

Sort: Relevancy | Date

News Conference News ACC 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

L.A. McKeown

March 04, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

L.A. McKeown

February 17, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

L.A. McKeown

January 13, 2023

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Todd Neale

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News AHA 2022

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

L.A. McKeown

November 11, 2022

News Conference News AHA 2022

STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends

Todd Neale

November 07, 2022

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

News Daily News

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

Shelley Wood

October 17, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

Advertisement

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

What’s Going to Be Hot at ACC/WCC 2023?

Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression

February 2023 News Roundup

Vast Majority of HFrEF Patients Eligible for Vericiguat

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

‘Agnostic’ EHR Alerts Boost VTE Prophylaxis in Hospitals and Postdischarge

STRONG-HF: Rapid Uptitration of GDMT After Acute HF Pays Dividends

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

October 2022 News Roundup

Most Patient-Reported Outcome Measures in CVD Fall Short

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content